PhRMA Public Affairs Calendar For February
Tuesday February 1: CEO edit call (Zenner); State Media tours on price controls begin
You may also be interested in...
PhRMA's new chief lobbyist heading into the 2000 Medicare reform debate will be former TRW VP-Government Relations James Christy.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.